Published in PLoS One on November 20, 2014
DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways. Neoplasia (2017) 0.75
Reversal of DDK-Mediated MCM Phosphorylation by Rif1-PP1 Regulates Replication Initiation and Replisome Stability Independently of ATR/Chk1. Cell Rep (2017) 0.75
The structural basis of the dominant negative phenotype of the Gαi1β1γ2 G203A/A326S heterotrimer. Acta Pharmacol Sin (2016) 0.75
Cell division cycle 7-kinase inhibitor PHA-767491 hydrochloride suppresses glioblastoma growth and invasiveness. Cancer Cell Int (2016) 0.75
The conformational plasticity of protein kinases. Cell (2002) 11.21
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc (2007) 9.92
Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer (2009) 9.26
Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol (2004) 3.57
The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem (2000) 3.49
Cdc7p-Dbf4p kinase binds to chromatin during S phase and is regulated by both the APC and the RAD53 checkpoint pathway. EMBO J (1999) 3.03
mcm5/cdc46-bob1 bypasses the requirement for the S phase activator Cdc7p. Proc Natl Acad Sci U S A (1997) 3.01
How do Cdc7 and cyclin-dependent kinases trigger the initiation of chromosome replication in eukaryotic cells? Genes Dev (2010) 2.88
Recognizing and exploiting differences between RNAi and small-molecule inhibitors. Nat Chem Biol (2007) 2.31
K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene (1992) 2.20
A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity. Nat Chem Biol (2008) 2.18
Phosphorylation of MCM4 by Cdc7 kinase facilitates its interaction with Cdc45 on the chromatin. J Biol Chem (2006) 2.14
Probing the probes: fitness factors for small molecule tools. Chem Biol (2010) 2.08
Identification of Mcm2 phosphorylation sites by S-phase-regulating kinases. J Biol Chem (2006) 2.04
Mammalian Cdc7-Dbf4 protein kinase complex is essential for initiation of DNA replication. EMBO J (1999) 2.01
Cell type-specific responses of human cells to inhibition of replication licensing. Oncogene (2002) 1.91
An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage. Cancer Res (2000) 1.78
Cdc28-Clb5 (CDK-S) and Cdc7-Dbf4 (DDK) collaborate to initiate meiotic recombination in yeast. Genes Dev (2008) 1.68
Dbf4-dependent CDC7 kinase links DNA replication to the segregation of homologous chromosomes in meiosis I. Cell (2008) 1.63
Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). J Med Chem (2007) 1.61
Cdc7-dependent phosphorylation of Mer2 facilitates initiation of yeast meiotic recombination. Genes Dev (2008) 1.60
Dbf4p, an essential S phase-promoting factor, is targeted for degradation by the anaphase-promoting complex. Mol Cell Biol (2000) 1.52
Inhibiting the expression of DNA replication-initiation proteins induces apoptosis in human cancer cells. Cancer Res (2003) 1.46
Physiological relevance of cell cycle kinases. Physiol Rev (2011) 1.44
Small molecule inhibitors of the RNA-dependent protein kinase. Biochem Biophys Res Commun (2003) 1.41
Cell cycle control of Cdc7p kinase activity through regulation of Dbf4p stability. Mol Cell Biol (1999) 1.41
Cdc7 inhibition reveals a p53-dependent replication checkpoint that is defective in cancer cells. Cancer Res (2004) 1.37
A novel growth- and cell cycle-regulated protein, ASK, activates human Cdc7-related kinase and is essential for G1/S transition in mammalian cells. Mol Cell Biol (1999) 1.34
CDC7 kinase phosphorylates serine residues adjacent to acidic amino acids in the minichromosome maintenance 2 protein. Proc Natl Acad Sci U S A (2006) 1.34
Cdc7-Drf1 kinase links chromosome cohesion to the initiation of DNA replication in Xenopus egg extracts. Genes Dev (2008) 1.34
Gene expression in poorly differentiated papillary thyroid carcinomas. Thyroid (2006) 1.21
Targeting cell division cycle 7 kinase: a new approach for cancer therapy. Clin Cancer Res (2010) 1.20
Bipartite binding of a kinase activator activates Cdc7-related kinase essential for S phase. J Biol Chem (2001) 1.20
Cdc7-Dbf4 kinase overexpression in multiple cancers and tumor cell lines is correlated with p53 inactivation. Neoplasia (2008) 1.18
K-252a, a potent inhibitor of protein kinase C from microbial origin. J Antibiot (Tokyo) (1986) 1.12
Structural changes in Mcm5 protein bypass Cdc7-Dbf4 function and reduce replication origin efficiency in Saccharomyces cerevisiae. Mol Cell Biol (2007) 1.08
A conserved domain of Schizosaccharomyces pombe dfp1(+) is uniquely required for chromosome stability following alkylation damage during S phase. Mol Cell Biol (2002) 1.08
Phosphorylated Rad18 directs DNA polymerase η to sites of stalled replication. J Cell Biol (2010) 1.06
The impact of PKR activation: from neurodegeneration to cancer. FASEB J (2014) 1.04
Molecular architecture of the DNA replication origin activation checkpoint. EMBO J (2010) 1.04
Cdc7 kinase inhibitors: pyrrolopyridinones as potential antitumor agents. 1. Synthesis and structure-activity relationships. J Med Chem (2008) 1.01
ATR-Chk1-APC/CCdh1-dependent stabilization of Cdc7-ASK (Dbf4) kinase is required for DNA lesion bypass under replication stress. Genes Dev (2013) 0.98
The design, synthesis, and biological evaluation of PIM kinase inhibitors. Bioorg Med Chem Lett (2012) 0.98
Cdc7 kinase is a predictor of survival and a novel therapeutic target in epithelial ovarian carcinoma. Clin Cancer Res (2009) 0.98
Cell cycle regulation of chromatin binding and nuclear localization of human Cdc7-ASK kinase complex. Genes Cells (2003) 0.94
Mechanisms of action of a dual Cdc7/Cdk9 kinase inhibitor against quiescent and proliferating CLL cells. Mol Cancer Ther (2011) 0.93
Crystal structure of human CDC7 kinase in complex with its activator DBF4. Nat Struct Mol Biol (2012) 0.91
ATR-dependent activation of p38 MAP kinase is responsible for apoptotic cell death in cells depleted of Cdc7. J Biol Chem (2008) 0.90
Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer. Hum Pathol (2009) 0.90
Discovery of XL413, a potent and selective CDC7 inhibitor. Bioorg Med Chem Lett (2012) 0.90
Dbf4 and Cdc7 proteins promote DNA replication through interactions with distinct Mcm2-7 protein subunits. J Biol Chem (2013) 0.89
Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents. Cancer Lett (2013) 0.88
First Cdc7 kinase inhibitors: pyrrolopyridinones as potent and orally active antitumor agents. 2. Lead discovery. J Med Chem (2009) 0.88
Synthesis and evaluation of pyrido-thieno-pyrimidines as potent and selective Cdc7 kinase inhibitors. Bioorg Med Chem Lett (2008) 0.87
Budding yeast Dbf4 sequences required for Cdc7 kinase activation and identification of a functional relationship between the Dbf4 and Rev1 BRCT domains. Genetics (2009) 0.87
Molecular mechanism of activation of human Cdc7 kinase: bipartite interaction with Dbf4/activator of S phase kinase (ASK) activation subunit stimulates ATP binding and substrate recognition. J Biol Chem (2011) 0.85
Cell division cycle 7 kinase inhibitors: 1H-pyrrolo[2,3-b]pyridines, synthesis and structure-activity relationships. J Med Chem (2009) 0.84
Cdc7 kinase inhibitors: 5-heteroaryl-3-carboxamido-2-aryl pyrroles as potential antitumor agents. 1. Lead finding. J Med Chem (2010) 0.83
Mechanism of cancer cell death induced by depletion of an essential replication regulator. PLoS One (2012) 0.83
Expression of huCdc7 in colorectal cancer. World J Gastroenterol (2013) 0.79
High expression of cell division cycle 7 protein correlates with poor prognosis in patients with diffuse large B-cell lymphoma. Med Oncol (2012) 0.79
Characterization of a Dual CDC7/CDK9 Inhibitor in Multiple Myeloma Cellular Models. Cancers (Basel) (2013) 0.77
Effects of CDC7 gene silencing and Rituximab on apoptosis in diffuse large B cell lymphoma cells. J Cancer Res Clin Oncol (2012) 0.76
N-substituted azaindoles as potent inhibitors of Cdc7 kinase. Bioorg Med Chem Lett (2013) 0.76